Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

Sexuality The American Journal of Medicine

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Discharge Heart Rate and Mortality after Acute Myocardial Infarction

Alternative Smoking Cessation Aids: A Meta-analysis of Randomized Controlled Trials Mehdi Tahiri, MD, Salvatore Mottillo, MD, Lawrence Joseph, PhD, Louise.

Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Alternative Smoking Cessation Aids: A Meta-analysis of Randomized Controlled Trials Mehdi Tahiri, MD, Salvatore Mottillo, MD, Lawrence Joseph, PhD, Louise.

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

30-Day Readmissions After an Acute Kidney Injury Hospitalization

Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure Ali Ahmed, MD, MPH, Robert C. Bourge, MD,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Overview of Current Learning Theories for Medical Educators

Schizophrenia for Primary Care Providers: How to Contribute to the Care of a Vulnerable Patient Population Mark Viron, MD, Travis Baggett, MD, MPH, Michele.

Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation Giulia Renda, MD, PhD, Marco.

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

Epidemiology of Myelodysplastic Syndromes

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Trend in Mortality after Stroke with Atrial Fibrillation

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Use of Targeted Temperature Management After Out-of-hospital Cardiac Arrest: A Meta- Analysis of Randomized Controlled Trials Ahmed Mahmoud, MD, Islam.

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D

A Plethora of Protein The American Journal of Medicine

Tick Tock The American Journal of Medicine

Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction Victoria Hamill, PhD, Ian Ford, PhD, Kim Fox, MD,

Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction Sripal Bangalore, MD, MHA, Gregg.

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Renato D. Lopes, MD, MHS, PhD, Meena Rao, MD,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

TIA for the Internist The American Journal of Medicine

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial Daniel H. Solomon, MD, MPH, M. Elaine.

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Repeated Hemoglobin A1C Ordering in the VA Health System

Molly E. Waring, PhD, Jane S

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction Marjan Mujib, MD, MPH, Kanan Patel, MBBS, MPH,

Prevalence and Risk Factors for Erectile Dysfunction in the US

Nilay S. Shah, MD, MPH, David Leonard, PhD, Carrie E

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

To Reduce Stroke with PFO Closure, Respect the Shunt

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W

Effect of Folic Acid, with or without Other B Vitamins, on Cognitive Decline: Meta- Analysis of Randomized Trials David S. Wald, MA, MRCP, MD, Anuradhani.

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure Cherinne Arundel,

The American Journal of Medicine

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation Giulia Renda, MD, PhD, Marco.

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Presentation transcript:

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel, MBBS, MPH, Mustafa I. Ahmed, MD, Gregg C. Fonarow, MD, Michael W. Rich, MD, Inmaculada B. Aban, PhD, Maciej Banach, MD, PhD, Thomas E. Love, PhD, Michel White, MD, Wilbert S. Aronow, MD, Andrew E. Epstein, MD, Ali Ahmed, MD, MPH The American Journal of Medicine Volume 126, Issue 10, Pages 887-893 (October 2013) DOI: 10.1016/j.amjmed.2013.04.021 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Absolute standardized differences comparing baseline characteristics of the subset of AFFIRM patients 70-80 years of age with atrial fibrillation randomized to rate-control versus rhythm-control strategies, before and after propensity score matching. The American Journal of Medicine 2013 126, 887-893DOI: (10.1016/j.amjmed.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Kaplan-Meier plot for all-cause mortality among a propensity-matched subset of AFFIRM patients aged 70-80 years with atrial fibrillation, by rate-control versus rhythm-control strategies. CI = confidence interval; HR = hazard ratio. The American Journal of Medicine 2013 126, 887-893DOI: (10.1016/j.amjmed.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Effect of a rate-control (vs rhythm-control) strategy on all-cause mortality in subgroups of propensity-matched subset of AFFIRM patients aged 70-80 years with atrial fibrillation. CI = confidence interval. The American Journal of Medicine 2013 126, 887-893DOI: (10.1016/j.amjmed.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions